Vigonvita Life Sciences Co., Ltd. (hereinafter referred to as “Vigonvita”), founded in 2013, was listed on the Hong Kong Stock Exchange in November 2025, with the stock code 2630.HK.
Vigonvita is an innovation-driven biopharmaceutical company committed to improving patient health and quality of life. Vigonvita focuses on pioneering new drug development in the fiel